IGF1 and diabetes mellitus: Preclinical rat studies have shown neonatal hypoxia-ischaemia as a precursor to diabetes, metabolic syndrome and stroke (Mcpherson et al., 2009), and IGF1 treatment offers neuroprotection after hypoxia-ischaemia (Brywe et al., 2005).